People on Ozempic and other GLP-1 agonist drugs commonly report they no longer have constant, incessant thoughts about food. This is how the drugs work.

between dosed animals and control animals (Table 1). There were no histological signs of pancreatitis in any repeat-dose toxicity studies in rats. PCNA staining indicated cell proliferation within ...

The following is a summary of “Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a ...

Despite comments made by a Novo Nordisk official this week, the company confirmed to BioSpace that it has no additional ...

Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...

The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

The deal gives the Swiss pharma access to an experimental amylin-targeting treatment it will test in combination with drugs ...

Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it expects double-digit revenue and core profit ...

GLP-1 agonists (also called GLP-1 receptor agonists or GLP-1 analogues) are usually injectable medications that help manage blood sugar levels in people with type 2 diabetes. They do this by ...